CHAOJU EYE CARE's stock surged 5.81% during intraday trading on Wednesday, following the company's announcement of a proposed final dividend for fiscal 2025.
The ophthalmic services provider proposed a final dividend of HKD 0.24 per share, with shareholders set to vote on the proposal in May 2026. This move to return cash to shareholders appears to have driven positive investor sentiment.
Concurrently, the company reported its fiscal 2025 results, which showed a 4.7% decline in net profit to RMB 177 million and a 3.2% drop in revenue to RMB 1.4 billion. The company cited intensified price competition and policy impacts from medical insurance reforms. Despite the profit decline, the firm expanded its network and reiterated expansion plans in Northern China and the Yangtze River Delta region.